Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on January 24th, 2023%
The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate. . . . → Read More: Trial Underway Testing Bioelectronic Incontinence Device
By Alan, on January 9th, 2023%
Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes
By Alan, on January 6th, 2023%
The biotechnology company BioNTech SE is partnering with the U.K. government to provide up to 10,000 personalized cancer immunotherapy treatments by 2030. . . . → Read More: BioNTech to Provide Personal Cancer Immunotherapies in UK
By Alan, on December 14th, 2022%
A new business is underway developing gene therapies with higher capacities than most current technologies to treat neurodegenerative disorders. . . . → Read More: New Company Creating High-Capacity Gene Therapies to the Brain
By Alan, on December 13th, 2022%
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds. . . . → Read More: Mental Health VR Companies Merge, Raise $13M
By Alan, on December 6th, 2022%
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
By Alan, on November 30th, 2022%
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M
By Alan, on November 14th, 2022%
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design
By Alan, on October 27th, 2022%
Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors
By Alan, on October 26th, 2022%
Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease. . . . → Read More: Trial Shows Antibody Neutralizes, Reduces HIV Virus
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|